Much attention has focused on the increasing prevalence of childhood type 2 diabetes mellitus. However, considerable evidence suggests that the incidence of childhood type 1 diabetes mellitus is also ...
In early January, the US Food and Drug Administration (FDA) granted an orphan drug status to the immunotherapy drug DV-0100, manufactured by the technology company DiaVacs. 1 This cell-based therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results